Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Life Sciences|February 23, 1987
4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicityI Irwin, J W Langston, L E DeLanneyLife Sciences|February 23, 1987
The biotransformation of MPTP and disposition of MPP+: the effects of agingJ W Langston, I Irwin, L E DeLanneyThe Journal of Experimental Zoology|December 1, 1983
A steady efflux of ionic current predicts hind limb development in the axolotlR B Borgens, M F Rouleau, L E DeLanneyNeuroscience Letters|January 16, 1995
Ultrastructure of eosinophilic inclusion bodies in the amygdala-parahippocampal region of aged squirrel monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxinL S Forno, L E DeLanney, I Irwin, et al.Brain Research|April 12, 1988
Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administrationG A Ricaurte, L E DeLanney, I Irwin, et al.Neuroscience Letters|April 22, 1988
The sensitivity of nigrostriatal dopamine neurons to MPP+ does not increase with ageI Irwin, G A Ricaurte, L E DeLanney, et al.Neuroscience Letters|June 5, 1989
The biodisposition of MPP+ in mouse brainI Irwin, L E DeLanney, D Di Monte, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1995
Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase BK T Finnegan, I Irwin, L E Delanney, et al.Neuropharmacology|January 1, 1987
Older dopaminergic neurons do not recover from the effects of MPTPG A Ricaurte, L E DeLanney, I Irwin, et al.Advances in Neurology|January 1, 1993
Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerationsL S Forno, L E DeLanney, I Irwin, et al.Pageof 5